Home > Healthcare > Drug Device Combination > Drug Filled Devices > Ureteral Stents Market

Ureteral Stents Market – By Product Type (Double Pigtail, Open-Ended, Close-Ended, Multiloop), By Application (Kidney Stones, Kidney Transplant, UTI), By Material (Metal, Polyurethane, Silicon, Hydrogel), By End-use – Global Forecast 2024 – 2032

  • Report ID: GMI8522
  • Published Date: Mar 2024
  • Report Format: PDF

Ureteral Stents Market Size

Ureteral Stents Market size was valued at around USD 470.6 million in 2023 and is expected to reach around USD 792.2 million by 2032 at a CAGR of 6% during the forecast period. The market is expected to experience growth driven by the increasing prevalence of urological disorders coupled with the rising demand for minimally invasive procedures.

Ureteral Stents Market

Ureteral stents are thin, flexible tubes made of medical-grade materials, designed for temporary placement within the ureters. These stents are used in medical procedures to alleviate obstruction or promote healing by providing a conduit for the passage of urine. A major factor contributing to the growing demand for ureteral stents is the rising incidence of kidney stone cases.

For instance, according to a study published by Science Direct, in 2022, Urolithiasis was one of the most common urologic diseases worldwide, with an estimated prevalence ranging from 1% to 13% in different regions across the globe. The steady increase in the prevalence of kidney stones globally is attributed to dietary habits, sedentary lifestyles, and inadequate hydration. As kidney stones obstruct the flow of urine from the kidneys to the bladder, ureteral stents play a pivotal role in relieving this obstruction and preventing complications such as hydronephrosis and renal damage.

Moreover, minimally invasive surgeries, such as endoscopic and laparoscopic procedures, are becoming more prevalent for treating urological disorders. Ureteral stents are often employed postoperatively to facilitate recovery, reduce complications, and enhance patient comfort. The evolution of these advanced techniques has led to a higher demand for these minimally invasive surgical instrument as an integral component of modern urological care, driving the market's growth.

Ureteral Stents Market Trends

Advancements in healthcare technology have played a pivotal role in shaping and improving various medical interventions, and this progress has significantly contributed to the growth and development of ureteral stents. These technological innovations have enhanced the design, placement procedures, and overall efficacy of ureteral stents, making them more efficient tools in the management of urological disorders.

  • The development of biomaterials and coatings has been a key driver in improving the safety and effectiveness of ureteral stents. Innovations in materials science have led to the use of substances that minimize irritation, inflammation, and encrustation, thereby enhancing patient comfort and reducing the need for premature stent removal. Coatings with antimicrobial properties also help prevent urinary tract infections associated with stent usage, further promoting their long-term viability.
  • Moreover, 3D printing technology has enabled the production of personalized and anatomically accurate ureteral stents. This customization allows healthcare professionals to tailor stents to fit the unique anatomy of each patient, optimizing the therapeutic outcome. Customized stents enhance comfort, reduce complications, and improve overall patient satisfaction, marking a significant leap forward in the application of healthcare technology in urology.

Ureteral Stents Market Analysis

Ureteral Stents Market, By Product Type, 2021 – 2032 (USD Million)

The market by product type is categorized into double pigtail, open-ended, close-ended, and multiloop. The double pigtail segment dominates the market with a revenue of around USD 177.8 million in 2023.

  • A double pigtail design is a distinctive feature in some ureteral stents where the ends of the stent curl into a double-looped or pigtail configuration. This design serves multiple purposes. The double pigtail helps anchor the stent in place within the kidney and bladder, reducing the risk of migration. Additionally, the coiled ends reduce irritation and trauma to the surrounding tissues, enhancing patient comfort during stent placement. This design innovation has become a hallmark of ureteral stents, contributing to their widespread use and acceptance in urological interventions.  
  • Moreover, the double-pigtail configuration effectively addresses the stent migration issue. The curled ends of the stent function as barriers, preventing unintentional movement within the ureter. This feature is particularly crucial in ensuring the longevity of the stent's therapeutic effects and reducing the need for frequent repositioning or replacement.

The ureteral stents market by application is categorized into kidney stones, kidney transplant, urinary tract infection, and other applications. The kidney stones segment dominates the market with a revenue of around USD 158 million in 2023.

  • Kidney stones can obstruct the normal flow of urine, causing excruciating pain and discomfort. Ureteral stents are often employed to alleviate this obstruction, allowing the natural passage of urine. By providing a temporary bypass for urine flow, stents effectively relieve the pain associated with kidney stones, making them a crucial component in the immediate management of this condition.
  • Surgical interventions, such as ureteroscopy or percutaneous nephrolithotomy, are often necessary for the removal of large or stubborn kidney stones. Ureteral stents are commonly placed postoperatively to promote healing, reduce swelling, and maintain the patency of the ureters. This application enhances the recovery process, underscoring the integral role of ureteral stents in comprehensive care for kidney stone patients, driving segment growth.

Based on the material, the ureteral stents market is segmented into metal stents, polyurethane stents, silicon stents, and hydrogel stents. The metal stents segment is anticipated to reach USD 289.5 million by 2032.

  • Metal stents, often made from alloys like nitinol or stainless steel, are known for their durability and long-lasting characteristics. This longevity is particularly beneficial in situations where extended stent indwelling times are required, such as in cases of chronic obstruction or recurrent urological conditions. The extended lifespan of metal stents enhances patient convenience by reducing the frequency of stent replacement.
  • Further, these stents possess superior radial force compared to their polymeric counterparts. This attribute is crucial in scenarios where stent expansion and resistance to compression are essential, such as in the treatment of strictures or areas prone to external compression. The enhanced radial force of metal stents contributes to their effectiveness in maintaining ureteral patency under challenging conditions, contributing to market growth positively.
Ureteral Stents Market, By End-use (2023)

The ureteral stents market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment dominates the market with a revenue of around USD 228.3 million in 2023.

  • Hospitals house skilled urologists, surgeons, and interventional radiologists who are adept at performing procedures involving ureteral stents. Surgical expertise is particularly vital in cases requiring complex interventions, such as stent placement post-surgery or in the management of challenging anatomical conditions. Hospitals' capacity for interventional procedures ensures that patients receive specialized care tailored to their unique urological needs.
  • Moreover, hospitals are equipped with advanced diagnostic facilities, including imaging modalities such as fluoroscopy, ultrasound, and CT scans. These technologies are crucial for the precise placement of ureteral stents. The accessibility of cutting-edge diagnostic tools within hospital settings enhances the accuracy and efficacy of ureteral stent procedures, contributing to their widespread adoption.
North America Ureteral Stents Market, 2020 – 2032 (USD Million)

North America ureteral stents market accounted for USD 190.6 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

  • North America experiences a significant prevalence of urological disorders, including conditions such as kidney stones, urinary tract infections (UTIs), and bladder-related issues. For instance, according to an article published by Medscape, in 2023, UTIs account for over 6 million patient visits to physicians per year in the U.S. The increasing incidence of these disorders has propelled the demand for ureteral stents, making North America a dominant market for these essential medical devices.
  • Moreover, North America is at the forefront of adopting and implementing technological innovations in the field of healthcare. The region consistently embraces new developments in medical devices, diagnostic tools, and treatment modalities. This includes the integration of advanced imaging technologies for precise stent placement and the use of novel materials in ureteral stent design. The rapid adoption of these innovations contributes to the dominance of North America in the global market.

Ureteral Stents Market Share

The ureteral stents industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for ureteral stent manufacturers.

Ureteral Stents Market Companies

Some of the eminent market participants operating in the ureteral stents industry include:

  • Allium Medical
  • B.Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast
  • Cook Medical
  • Olympus Corporation
  • Pnn Medical A/S
  • Teleflex Inc.
  • Uromed

Ureteral Stents Industry News:

  • In October 2020, Allium Medical Solutions Ltd., announced that its urological stents received CE Mark for a new indication for treating urethral fistula after a successful trial. This approval helped the company to acquire enhanced customer base.

Ureteral Stents Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • Double pigtail
  • Open-ended
  • Close-ended
  • Multiloop

Market, By Application

  • Kidney stones
  • Kidney transplant
  • Urinary tract infection
  • Other applications

Market, By Material

  • Metal stents
  • Polyurethane stents
  • Silicon stents
  • Hydrogel stents

Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ureteral stents industry was worth USD 470.6 million in revenue in 2023 and is expected to expand at 6% CAGR from 2024-2032 attributed to the increasing prevalence of urological disorders coupled with the rising need for minimally invasive procedures.

The double pigtail segment accounted for USD 177.8 million in revenue in 2023 and is estimated to record substantial growth through 2032 owing to the unique design innovation of ureteral stents, contributing to their widespread use and acceptance in urological interventions.

North America ureteral stents market generated USD 190.6 million in revenue in 2023 and is set to exhibit robust growth during 2024-2032 driven by the significant prevalence of urological disorders, including conditions, such as kidney stones, UTIs, and bladder-related issues.

Some of the major companies operating in the ureteral stents industry are Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Olympus Corporation, Pnn Medical A/S, Teleflex Inc., and Uromed.

Ureteral Stents Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 306
  • Countries covered: 22
  • Pages: 180
 Download Free Sample